Can a common gout drug cool down inflamed arteries in diabetics?
NCT ID NCT04181996
First seen May 07, 2026 · Last updated May 09, 2026 · Updated 1 time
Summary
This study looked at whether colchicine, a drug used for gout, can reduce inflammation in the arteries of people with diabetes or pre-diabetes who recently had a heart attack or stroke. Researchers used special PET scans to measure inflammation in the blood vessels. The goal was to see if colchicine could lower this inflammation and potentially prevent future heart problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mazankowski Alberta Heart Institute
Edmonton, Alberta, T6G 2B7, Canada
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Conditions
Explore the condition pages connected to this study.